Table 2.
Variables | Events | Person‐Years | Incidence Ratea | Events | Person‐Years | Incidence Ratea |
---|---|---|---|---|---|---|
EH | APA | |||||
CHF | 172 | 15 486 | 11.1 | 23 | 4327.9 | 5.3 |
Mortality | 312 | 16 372 | 19.1 | 25 | 4423.3 | 5.7 |
Comparison of CHF and Mortality Risks in APA vs EH Patients | ||||||
---|---|---|---|---|---|---|
HR | P Value | Adjusted HR (95% CI) | P Value | HR Competing With Mortality (95% CI) | P Value | |
CHF | 0.49 (0.32–0.76) | 0.001 | 0.49 (0.31–0.75) | 0.001 | 0.51 (0.33–0.79) | 0.002 |
Mortality | 0.30 (0.20–0.45) | <0.001 | 0.29 (0.20–0.44) | <0.001 |
APA indicates aldosterone producing adenoma; CHF, congestive heart failure; EH, essential hypertension; HR, hazard ratio; PA, primary aldosteronism.
Per 1000 person‐years.